GlassScriptPhysician profile
Kristin Mctighe
NPI 1952761553
$1,152.14
in general payments reported to CMS, 2019-2025
9 companies · $1,022 in 2025
The $1,022 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $130 · 2025: $1,022.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,152.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $255.48 | 2024-2025 | Tremfya |
| Ipsen Biopharmaceuticals, INC | $255.04 | 2025 | Iqirvo, Bylvay, Onivyde |
| Janssen Scientific Affairs, LLC | $239.95 | 2025 | Tremfya |
| Madrigal Pharmaceuticals | $139.37 | 2025 | Rezdiffra |
| Lilly USA, LLC | $138.51 | 2025 | Omvoh |
| Abbvie INC. | $58.02 | 2025 | |
| Genzyme Corporation | $25.37 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.42 | 2025 | Xifaxan, Plenvu |
| Merck Sharp & Dohme LLC | $19.98 | 2025 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristin Mctighe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.